Open and transparent ? Read our concerns over the WHO Expert Working Group process
Treating Too Few, Too Late Read about the case for starting ARV treatment earlier in developing countries click here
An ideal TB test ? Read interview with Access Campaign director
Job openings at the Campaign We are looking for a Medical Innovation Policy Adviser and an EU Policy Advocacy Assistant Read more
|
 |
|
 |
|
 |
AMC - A New Deal To Boost Production Of Life-Saving Vaccines: What The Doctor Ordered?12 June 2009 |
|
|
Geneva/Roma – A number of governments and GAVI Alliance have officially committed today to pay a set price for significant quantities of pneumococcal vaccines in a bid to speed up its roll-out in... |
|
Chagas disease not addressed by World Health Assembly - Neglected disease neglected once again19 May 2009 |
|
|
MSF urges affected countries to scale up diagnosis and treatment on 100th anniversary of the disease’s discovery Barcelona/Geneva –The World Health... |
|
NECT Added to WHO Essential Medicines List as Combination Treatment Against Sleeping Sickness15 May 2009 |
|
|
Geneva, Switzerland - NECT (Nifurtimox-Eflornithine Combination Therapy), a new treatment option against sleeping sickness, a fatal disease which threatens 60... |
|
Price of Generic AIDS Drugs Slashed - Patents Prevent Some Countries from Accessing the Cheaper Drugs20 April 2009 |
|
|
Geneva - UNITAID and the Clinton Foundation’s HIV/AIDS Initiative (CHAI) have just announced price reductions negotiated with generic companies for 41 adult... |
|
New Malaria Drug Subsidy Fails to Ensure Patients Receive Best Treatment Options08 April 2009 |
|
|
Geneva – 8 April 2009 – A global malaria drug subsidy to be launched this month is failing to look at medical needs and is jeopardising the future of the most... |
|
People with Drug-Resistant Tuberculosis Neglected by Governments31 March 2009 |
|
|
Beijing – 31st March 2009 – Countries that are facing the heaviest toll of multidrug-resistant tuberculosis (MDR-TB) are not moving fast enough to provide life-saving treatment, according to... |
|
MSF and DNDi call for scale-up of R&D for neglected diseases23 February 2009 |
|
|
Greater Governmental Leadership is needed to Foster Medical Innovation for Millions Suffering from Neglected Diseases Geneva/New York, February 23, 2009: The international medical... |
|
MSF response to GSK patent pool proposal16 February 2009 |
|
|
A welcome first step - but HIV is also a neglected disease Statement by Michelle Childs, Director of Policy and Advocacy, Campaign for Access to Essential Medicines,... |
|
MSF halts efforts to open MDR TB project in China16 February 2009 |
|
|
Beijing/Brussels, 10 February 2009. After attempting for almost two years to reach an agreement with China’s TB Control Program, Medecins Sans Frontieres (MSF) has given up on its efforts to start a... |
|
MSF Response to G-FINDER report 200905 February 2009 |
|
|
Statement by Dr. Tido von Schoen-Angerer, Director of the Campaign for Access to Essential Medicines, Médecins Sans FrontièresIn response to the publication of the G-FINDER... |
|
